Skip to main content
Premium Trial:

Request an Annual Quote

NHGRI Approves $400K Grant to Help BioForce Develop Surface Patterning Tool

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute has approved $400,000 in funding for BioForce Nanosciences to help the company in the second commercial development phase of its surface patterning tools, BioForce said today.
 
SPT molecular ink cartridges are used in the company's core Nano eNabler benchtop molecular printing system.
 
"The next phase of our SPT cartridge development program focuses on the improvement and expansion of the capabilities and throughput of the devices," Curtis Mosher, vice president of R&D at BioForce, said in a statement. "SPT cartridge loading and cleaning in place are primary objectives of the ongoing program."
 
The company said that when the SPT portfolio is complete, customers “should be able to print spots, lines and complex paths of one or many different molecules or compounds."
 
The funding includes the “potential” for an additional $400,000 after Aug. 31, 2007, BioForce said in a statement.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.